Rheopheresis for recurrent sudden hearing loss: Therapeutic options for patients refractory to infusion therapy;Rheopherese bei rezidivierendem Hörsturz: Therapieoption für Patienten nach erfolgloser Infusionstherapie

HNO

Volumn 58, Issue 5, 2010, Pages 445-451

  Uygun Kiehne, S ^a   Straube, R ^a   Heibges, A ^b   Klingel, R ^b   Davids, H ^a  

^a Klinikum Ludenscheid   (Germany)

^b Apherese Forschungsinstitut   (Germany)

Author keywords

Fibrinogen LDL apheresis; Infusion therapy; Microcirculation; Recurrent sudden hearing loss; Rheopheresis

Indexed keywords

ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; INFANT; INFUSION; MALE; METHODOLOGY; PLASMAPHERESIS; PRESCHOOL CHILD; RECURRENT DISEASE; SUDDEN DEAFNESS; TREATMENT FAILURE; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; FEMALE; HEARING LOSS, SUDDEN; HOME INFUSION THERAPY; HUMANS; INFANT; MALE; PLASMAPHERESIS; RECURRENCE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 77952323490     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-009-2004-2     Document Type: Article

References (31)

1. Alles MJ, der Gaag MA, Stokroos RJ (2006) Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 263: 791-797.
2. Balletshofer BM, Stock J, Rittig K et al (2005) Acute effect of Rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss. Ther Apher Dial 9: 385-390.
3. Burschka MA, Hassan HA, Reineke T et al (2001) Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol 258: 213-219.
4. Canis M, Heigl F, Hettich R et al (2008) H. E. L. P.-Apherese bei der Behandlung des Hörsturzes - Eine Anwendungsbeobachtung an 152 Patienten. HNO 9: 961-966.
5. Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss - I. A systematic review. Arch Otolaryngol Head Neck Surg 133: 573-581.
6. Conlin AE, Parnes LS (2007) Treatment of sudden sensorineural hearing loss - II. A meta-analysis. Arch Otolaryngol Head Neck Surg 133: 582-586.
7. DIN 45621-1 (1995) Freiburger Sprachtest, Sprache für Gehörprüfung - Teil 1: Ein- und mehrsilbige Wörter. DIN 45621-2 (1980) Sprache für Gehörprüfung - Teil 2: Sätze.
8. Domachevsky L, Keynan Y, Shupak A, Adir Y (2007) Hyperbaric oxygen in the treatment of sudden deafness. Eur Arch Otorhinolaryngol 264: 951-953.
9. Deutsche Ges. f. HNO-Heilkunde, Kopf- und Halschirurgie (2009) Neue Leitlinie Hörsturz 2009. Persönliche Kommunikation Prof. R. Mösges, im Druck.
10. Feldmann H (2006) Tabelle zur Ermittlung der MdE aus den Schwerhörigkeitsgraden beider Ohren. In: Das Gutachten des Hals-Nasen-Ohren-Arztes, 6. Aufl. Georg Thieme, Stuttgart New York, S 101.
11. Fujimura T, Suzuki H, Shiomori T et al (2007) Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 264: 861-866.
12. Guo Y, Zhang C, Du X et al (2005) Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear Res 208: 54-67.
13. ISO 7029 (2000) Ausgabe 2000-05, Akustik - Statistische Verteilung von Hörschwellen als eine Funktion des Alters [Acoustics. Statistical distribution of hearing tresholds as a function of age].
14. Kirschkamp T, Schmid-Schönbein H, Weinberger A, Smeets R (2008) Effects of fibrinogen and alpha2-macroglobulin and their apheretic elimination on general blood rheology and rheological characteristics of red blood cell aggregates. Ther Apher Dial 12: 360-367.
15. Klemm E, Deutscher A, Mösges R (2009) Aktuelle Stichprobe zur Epidemiologie des idiopathischen Hörsturzes. Laryngorhinootologie 88: 524-527. doi 10. 1055/s-0028-1128133.
16. Klemm E, Schaarschmidt W (1986) Epidemiologic study of labyrinth disorders. Z Ärztl Fortbild 80: 905-907.
17. Klingel R, Erdtracht B, Gauss V et al (2005) Rheopheresis in patients with critical limb ischemia - Results of an open label prospective pilot trial. Ther Apher Dial 9: 473-481.
18. Klingel R, Fassbender C, Fassbender T, Göhlen B (2003) Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based medicine. Transfus Apher Sci 29: 71-84.
19. Klingel R, Mumme C, Fassbender T et al (2003) Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial. Ther Apher Dial 7: 444-455.
20. Koc A, Sanisoglu O (2003) Sudden sensorineural hearing loss: Literature review on recent studies. J Otolaryngol 32: 308-313.
21. Maass B (1982) Innenohrdurchblutung - Anatomisch-funktionelle Betrachtungen. HNO 30: 355-364.
22. Michel O (1994) Der Hörsturz. Georg Thieme, Stuttgart New York.
23. Michel O (2000) The antiphlogistic-rheological infusion protocol ("Stennert's protocol") for the treatment of cochleo-vestibular disorders. HNO 48: 182-188.
24. Mösges R, Köberlein J, Heibges A et al (2009) Rheopheresis for idiopathic sudden hearing loss: results from a large prospective, multicenter, randomized, controlled clinical trial. Eur Arch Otorhinolaryngol 266: 943-953. doi 10. 1007/s00405-008-0823-5.
25. Nguyen TV, Brownell WE (1998) Contribution of membrane cholesterol to outer hair cell lateral wall stiffness. Otolaryngol Head Neck Surg 119: 14-20.
26. Ohinata Y, Makimoto K, Kawakami M et al (1994) Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolaryngol 114: 601-607.
27. Olzowy B, Osterkorn D, Suckfüll M (2005) The incidence of sudden hearing loss is greater than previously assumed. MMW Fortschr Med 47: 37-38.
28. Rajagopalan L, Greeson JN, Xia A et al (2007) Tuning of the outer hair cell motor by membrane cholesterol. J Biol Chem 282: 36659-36670.
29. Rauch SD (2008) Idiopathic sudden sensorineural hearing loss. N Engl J Med 359: 833-840.
30. Suckfüll M (2002) Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 360: 1811-1817.
31. Suckfüll M, Wimmer C, Reichel O et al (2002) Hyperfibrinogenemia as a risk factor for sudden hearing loss. Otol Neurotol 23: 309-311.